Conditions: Carcinoma
Keywords: Safety PK Biomarker
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
To evaluate the clinically recommended dose of AG-013736 (Axitinib) in Japanese patients by reviewing the safety of AG-013736 (Axitinib) following single and multiple dosing.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Axitinib (AG-013736)
Intervention descriptions: intervention 1: AG-013736 5mg twice daily \[BID\]

Protocol document: